A Global Health & Research Company
Let’s Accelerate the Future of Health Together
Future of Medicine health screenings are here
Make your studies available to Future of Medicine Members
Research Sites across the globe
We establish and conduct high-quality research operations wherever they are needed
On-site or centralized staff available
Site Support Solutions provides resources and staffing support for your study sites.
What We Do
1
Clinical Research Sites and Support
Our global network of sites and PIs provide centralized and decentralized research services.
- Care Access Site Network
- Sites On Demand™
- Virtual PIs and regional sites
- Mobile research capabilities and infrastructure
- Specialized staff augmentation
- Centralized research staff
- Training programs
2
Community Health Screening
We conduct large-scale community-based health screenings that streamline access to clinical research studies.
- Ongoing pre-screening activity
- Independent of study protocols
- Sites can start enrolling at study activation
- Multiple therapeutic areas
- Deep-rooted community partnerships
- Better study representation
Our Reach
We operate in 19 countries including the United States, Canada, Brazil, and Poland. New operations coming soon to the UK, Italy, and the Netherlands.
200+
Permanent Site Locations
250+
Investigators
150+
Mobile Health Clinics
~450
Clinical Research Professionals
300+
Clinical Trials
14
Therapeutic Areas
100,000+
Patients screened per year
~20M
Patient Network
Active Studies
Therapeutic Areas
Cardiology
Dermatology
Endocrinology
Family Practice
Gastrointestinal
Gynecology
Infectious Disease
Internal Medicine
Neurology
Oncology
Psychiatry
Pulmonology
Rheumatology
Vaccine
Our Journey
Redefining What’s Possible in Clinical Research
Throughout our history, Care Access has consistently developed novel solutions to major constraints in the traditional clinical trial model. Now, we’ve integrated our proven solutions and practical experience into a leading-edge delivery model that accelerates study recruitment times while improving access to research in more communities.
See how we’re evolving the way that clinical trials are conducted to match the rapid pace of today's medical discoveries.
New PI Development
Phase
2
Gastroenterology
~5 new sites
Created a system for enabling new-to-research physicians to become PIs with 360° support from experienced staff, helping address the industry-wide PI shortage.
Rapid New PI Development
Phase
2
Immunology
~20 new sites
Scaled our PI development capability to rapidly create new research sites and accelerate enrollment for a specific study that had few feasible sites.
Multi-Site PI
Phase
3
Home Infusions
~50 new sites
Developed the model for remote PI oversight, which reduces the burden on on-site sub-investigators and enables research studies to be offered in more locations.
At-Home IP Dosing
Phase
3
Infectious Disease
~5 new sites
Built leading-edge mobile infrastructure and logistics to precisely manage investigational products anywhere, even in places where research infrastructure doesn’t yet exist.
Centralized Virtual Staff
Phase
3
Neurology
100+ new sites
Implemented a remote central team to efficiently manage study tasks, allowing local site staff to focus on work that requires in-person activity.
Pop-Up Mobile Sites
Phase
3
Vaccine
~30 new sites
Combined PI development, multi-site PI, advanced IP management, centralized virtual staff, and mobile infrastructure to rapidly build mobile sites in areas with very limited research infrastructure.
Pop-Up In-Clinic Sites
Phase
3
Pulmonary
~30 new sites
Extended our pop-up mobile site model to medical clinics, making study participation possible for communities underserved by clinical research.
Split Screening & Enrollment
Phase
3
Cardiometabolic
~60 new sites
Designed and implemented a study-agnostic pre-screening program that offloads pre-screening work from research sites, so they can begin enrolling participants immediately when studies are activated.
Presentation
Adoptability as the Necessary Criteria for Impactful Innovation
We support sponsors across their portfolios. For the highest-priority studies, we bring unique solutions.
Super Site Capabilities
Care Access further supports the industry with Super Site Capabilities that augment the traditional research site.
Permanent Site Locations
- Traditional Research Sites
- State-of-the-Art Facilities
- Long-Term Community Connections
- Function as Site Network Logistics Hubs
Centralized Clinical Operations
- Quality System
- Virtual PIs when valuable
- Study Management
- Site Orchestration
- Control Tower
Mobile Research Site Infrastructure
- Mobile Clinical Research Vehicles, Trailers
- Traveling Sub-Investigators
- Traveling Clinical Research Staff
- IP Management & Transport
Patient Centric / Patient Convenience
- Patient Education
- High-Capacity Call Center
- Virtual Coordinators
Central Logistics
- Central Labs
- Distribution Hubs
- Fleet Shop
Grassroots Community Engagement
Our Commitment to Communities
We work with hundreds of communities each year to deliver care and research where it is most needed.
Through our Future of Medicine program, we provide our Members free health screenings, information about research studies, and other education and services.
And through our Difference Makers program, we support and amplify the impact of local leaders and organizations that work to improve their communities’ health and wellness.
Communities Embracing New Access to Research
Making Space for Clinical Trials in Senior Communities
Bringing a Lyme Disease Vaccine Trial to Rural Areas Where There Are No Research Sites
Diversity & Representation
Care Access partners with Sponsors to help achieve their research diversity and representation goals.
We take a grassroots approach to engaging with diverse and under-represented communities. Our Super Site Capabilities make clinical research available to those communities even when there is no existing clinical trials infrastructure.
Therapeutic Area Focus
Building Therapeutic Area Ecosystems.
Care Access hyper-focuses on a set of therapeutic areas that are high-priority for the industry and builds capabilities that strengthen our ability to support those studies. This includes: study-agnostic screening, scientific expertise via advisory board, and community awareness building around the condition.
Currently, we are building the following Therapeutic Area Ecosystems:
- Alzheimer’s
- Gastroenterology
- Cardiovascular
- Diabetes & Weight Management
- Infectious Disease
Learn more about our Cardiovascular Ecosystem
Collaborating with leading AMCs and HBCUs through American Heart Association (AHA) research network
Lp(a) screenings built around ecosystem of healthcare providers, community leaders, and individual ambassadors
Establishing Care Access’ Cardiology Scientific Advisory Board
Accelerating the Future of Medicine for Everyone
We’re not just providing more patients with access to innovative research studies, we’re making the future of health better for all.
With the support of 14 of the top 15 pharmaceutical and biotech partners, we are helping people learn more about their health, access health resources they need, and participate in research to help find new medicines and cures.
Interested in exploring how we can support your research studies?
Contact Us